These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12952733)

  • 1. Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?
    Poveda E; de Mendoza C; Cuesta M; Toro C; Rodés B; Soriano V
    AIDS Patient Care STDS; 2003 Jul; 17(7):321-4. PubMed ID: 12952733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular-based methods for quantifying HIV viral load.
    Peter JB; Sevall JS
    AIDS Patient Care STDS; 2004 Feb; 18(2):75-9. PubMed ID: 15006182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.
    Elbeik T; Charlebois E; Nassos P; Kahn J; Hecht FM; Yajko D; Ng V; Hadley K
    J Clin Microbiol; 2000 Mar; 38(3):1113-20. PubMed ID: 10699005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bDNA testing in the immunologically nonresponding patient who has a low or undetectable viral load by RT-PCR testing.
    Grimes RM; Lewis ST; Visnegarwala F; Goodly J; Sutton R; Rodriguez-Barradas M
    HIV Clin Trials; 2003; 4(2):92-8. PubMed ID: 12671776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Anastassopoulou CG; Touloumi G; Katsoulidou A; Hatzitheodorou H; Pappa M; Paraskevis D; Lazanas M; Gargalianos P; Hatzakis A
    J Virol Methods; 2001 Jan; 91(1):67-74. PubMed ID: 11164487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.
    Swanson P; Soriano V; Devare SG; Hackett J
    J Clin Microbiol; 2001 Mar; 39(3):862-70. PubMed ID: 11230396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
    Drexler JF; de Souza Luna LK; Pedroso C; Pedral-Sampaio DB; Queiroz AT; Brites C; Netto EM; Drosten C
    J Clin Microbiol; 2007 Jun; 45(6):2061-3. PubMed ID: 17392448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-level viremia associated with the use of TaqMan assay.
    Szabo S; Moffett LE; Cantwell-McNelis K; James CW; Joseph A
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):203-5. PubMed ID: 20530465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 viral load: comparative evaluation of three commercially available assays in Argentina.
    Hodara V; Monticelli A; Pampuro S; Salomón H; Jauregui Rueda H; Libonatti O
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):107-13. PubMed ID: 9695883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 proviral resistance mutations: usefulness in clinical practice.
    Kabamba-Mukadi B; Duquenne A; Henrivaux P; Musuamba F; Ruelle J; Yombi JC; Bodéus M; Vandercam B; Goubau P
    HIV Med; 2010 Sep; 11(8):483-92. PubMed ID: 20163482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).
    Si-Mohamed A; Andreoletti L; Colombet I; Carreno MP; Lopez G; Chatelier G; Kazatchkine MD; Belec L
    J Clin Microbiol; 2001 Jun; 39(6):2055-9. PubMed ID: 11376034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.
    Elbeik T; Alvord WG; Trichavaroj R; de Souza M; Dewar R; Brown A; Chernoff D; Michael NL; Nassos P; Hadley K; Ng VL
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):330-9. PubMed ID: 11917236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undetectable plasma HIV-1 RNA with strong gag-pol specific interferon-gamma ELISPOT response in an HIV-1 clade A/E-infected child untreated with antiretroviral therapy.
    Ananworanich J; Pancharoen C; Sirivichayakul S; Buranapraditkun S; Apateerapong W; Ubolyam S; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2004; 22(2-3):165-9. PubMed ID: 15565954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses.
    Swanson P; Huang S; Abravaya K; de Mendoza C; Soriano V; Devare SG; Hackett J
    J Virol Methods; 2007 Apr; 141(1):49-57. PubMed ID: 17184853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes.
    Chew CB; Herring BL; Zheng F; Browne C; Saksena NK; Cunningham AL; Dwyer DE
    J Clin Virol; 1999 Oct; 14(2):87-94. PubMed ID: 10588451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.
    Bronze M; Aitken SC; Wallis CL; Steegen K; Stuyver LJ; de Wit TF; Stevens W
    J Virol Methods; 2013 Dec; 194(1-2):300-7. PubMed ID: 23994150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.